Kolexia
Aparicio Thomas Gastro-entérologie
Aparicio Thomas
Gastro-entérologie
Hôpital Avicenne
Bobigny, France
395 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Métastase tumorale Tumeurs du côlon Tumeurs de l'estomac Instabilité des microsatellites Carcinomes Tumeurs du foie Tumeurs du rectum

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Lecomte Thierry
Lecomte Thierry
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
MSD
8 collaboration(s)
Dernière en 2023
Amgen
8 collaboration(s)
Dernière en 2021
Servier
7 collaboration(s)
Dernière en 2021
AstraZeneca
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOUNTAINEER-03: An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
Essai Clinique (Seagen)   15 mars 2024
COPERNIC: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Essai Clinique (Roche)   13 mars 2024
AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 février 2024
FOLFORINOX SBA: Randomized Phase II Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
Essai Clinique (CHU Dijon-Bourgogne)   19 février 2024
Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.
Scandinavian journal of gastroenterology   14 février 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 janvier 2024
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
British journal of cancer   15 décembre 2023
Feasability of a trimodal prehabilitation program in geriatric oncology
Clinical nutrition ESPEN   01 décembre 2023
GEMPAX: A Phase III Randomized Study Evaluating Gemcitabine and Paclitaxel Versus Gemcitabine Alone After FOLFIRINOX Failure or Intolerance in Metastatic Pancreatic Ductal Adenocarcinoma
Essai Clinique (Unicancer)   07 novembre 2023